2 small-cap growth stocks for ambitious investors

These two small-cap stocks could outperform the wider index in the long term.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Although small-cap stocks are generally considered to be riskier investments than more mature large-cap companies, they often deliver greater returns over the long term. Small-cap stocks are also more commonly mis-priced by investors due to behavioural biases and their perceived business risks, which enables investors to occasionally find some hidden gems.

With this in mind, I’m taking a look at two small-cap stocks with serious upside potential.

Buy and build

Scientific instrument specialist Judges Scientific (LSE: JDG) is a turnaround play which ambitious investors should keep an eye out for.

The core of the company’s business model is to buy and build a portfolio of scientific instrument businesses. Growth is being pursued by a combination of the pursuit of organic growth from existing businesses and through the acquisition of top-quality businesses with established reputations in specialist niches.

Although the past two years had been a tough time for the company, as growth in earnings and cash flow languished, the company is showing a number of signs that things could soon take a turn for the better. Despite a sluggish start to the year, trading picked up in the second half of 2016, with overall organic order intake up 2.9% compared with 2015.

Looking ahead, profitability is expected to improve as it addresses the production challenges in one of its businesses, which has primarily been the cause of the company’s recent weak financial performance. The company is also set to benefit from sterling’s relative weakness as the group earns a majority of its revenues from overseas, but its costs are predominately UK-based and are largely denominated in sterling.

What’s more, the long-term fundamentals of the scientific instrumentation sector remain intact, with demand likely to continue to grow due to increased investment in higher education and a growing trend towards optimisation across science and industry.

As City analysts expect the company to increase its earnings by 24% this year, investors would likely gain confidence in its turnaround prospects. Judges is currently attractively valued, with shares in the company trading at 15.2 times expected earnings this year (or 13.7 times expected earnings for 2018).

Infrastructure

Meanwhile, construction and engineering services company Renew Holdings (LSE: RNWH) could be set to benefit from an improving infrastructure spending outlook in the UK. The company has extensive expertise in the water, telecoms, transport and energy sectors and is well-placed to gain market share in the regulated infrastructure markets.

The company’s interim results this week show Renew is making solid progress. Revenue in the six months to 31 March 2017 increased 9%, while operating profit jumped by 14% to £12.1m. This enabled it to hike its interim dividend by 13% to 2.65p per share, giving its shares a current yield of 1.9%.

With management confident that it can lift the group’s operating margin to 4.5%, from 4.2% currently, I expect earnings to outpace revenue growth again this year. Renew seems reasonably priced, with shares in the company trading at 14.3 times expected earnings this year, which compares favourably to the sector average of 17.4.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Jack Tang has no position in any shares mentioned. The Motley Fool UK has recommended Judges Scientific. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young Caucasian girl showing and pointing up with fingers number three against yellow background
Investing Articles

3 stock market mistakes I’d avoid

Our writer explores a trio of things that can trip up investors who are new to the stock market. Each…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

Just released: our top 3 small-cap stocks to consider buying in October [PREMIUM PICKS]

Small-cap shares tend to be more volatile than larger companies, so we suggest investors should look to build up a…

Read more »

Investing Articles

How I’d use an empty Stocks and Shares ISA to aim for a £1,000 monthly passive income

Here's how using a Stocks and Shares ISA really could help those of us who plan to invest for an…

Read more »

Investing Articles

This FTSE stock is up 20% and set for its best day ever! Time to buy?

This Fool takes a look at the half-year results from Burberry (LON:BRBY) to see if the struggling FTSE stock might…

Read more »

Investing Articles

This latest FTSE 100 dip could be an unmissable opportunity to pick up cut-price stocks

The FTSE 100 has pulled back with the government’s policy choices creating some negative sentiment. But this gives us a…

Read more »

A young woman sitting on a couch looking at a book in a quiet library space.
Investing Articles

As the WH Smith share price falls 4% on annual results, is it still worth considering?

WH Smith took a hit after this morning’s results left shareholders unimpressed. With the share price down 4%, Mark Hartley…

Read more »

Investing Articles

The Aviva share price just jumped 4.5% but still yields 7.02%! Time to buy?

A positive set of results has put fresh life into the Aviva share price. Harvey Jones says it offers bags…

Read more »

Investing Articles

Can a €500m buyback kickstart the Vodafone share price?

The Vodafone share price has been a loser for investors in recent years, and the dividend has been cut. We…

Read more »